A review in Brain Medicine unveils the potential of targeted alpha particle therapy (TAT) as an innovative and exciting ...

In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...

The Axion Longitudinal Plasma Haloscope (ALPHA) experiment reached a milestone on February 24 with the successful installation of a Bluefors helium dilution fridge at the site of the experiment in ...

Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.